Market revenue in 2023 | USD 69.1 million |
Market revenue in 2030 | USD 87.7 million |
Growth rate | 3.5% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.34% in 2023. Horizon Databook has segmented the Middle East & Africa in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
Economic development, coupled with high unmet healthcare needs, fuels the growth of the Middle East and Africa IVD quality control market. The rate of diagnosis of diseases is low in the region. This has created major unmet needs for low-cost and efficient diagnostic tests and laboratories, which is expected to fuel the market over the coming years.
Moreover, multinational companies are adopting various favorable initiatives to increase their market share in the region. For instance, in January 2024, QIAGEN announced a significant expansion of its business in Middle Eastern countries, such as Saudi Arabia and Oman.
Investment in the healthcare industry is rising in the region, which can be attributed to an increased global focus on underdeveloped countries. Saudi Arabia and South Africa held significant shares of the MEA IVD quality control market in 2023, owing to high economic development and increasing market potential.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa in vitro diagnostics quality control market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account